These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25493030)

  • 1. Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.
    De Cassan C; Savarino E; Marson P; Tison T; Hatem G; Sturniolo GC; D'Incà R
    World J Gastroenterol; 2014 Dec; 20(45):17155-62. PubMed ID: 25493030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
    Nakano R; Iwakiri R; Ikeda Y; Kishi T; Tsuruoka N; Shimoda R; Sakata Y; Yamaguchi K; Fujimoto K
    J Gastroenterol Hepatol; 2013 Feb; 28(2):303-8. PubMed ID: 23339387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective granulocyte-monocyte apheresis during induction with vedolizumab in moderate-severe ulcerative colitis: Experience in a tertiary hospital.
    Suárez Ferrer C; Martin-Arranz E; Martín-Arranz MD
    Gastroenterol Hepatol; 2024; 47(7):721-726. PubMed ID: 38219961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
    Passalacqua S; Ferraro PM; Bresci G; D'Ovidio V; Astegiano M; Principi M; Testa R; D'Incà R; Valpiani D; Armuzzi A; Sablich R; Cavallaro F; Costa F; Di Leo V; Colombo E; Santini A; Aratari A; Lecis P; Saladino V; Riegler G; Marco M; Calella F; Ricci C; Guidi ML; Repaci G; Silla M
    J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
    Schultheiß C; Weischenberg R; Herrmann A; Haller B; Schmid RM; Reindl W; Huber W
    Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte/Monocyte Adsorptive Apheresis in Moderate to Severe Ulcerative Colitis--Effective or Not?
    Kruis W; Nguyen P; Morgenstern J
    Digestion; 2015; 92(1):39-44. PubMed ID: 26112696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
    Yamamoto T; Umegae S; Matsumoto K
    J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.
    Yokoyama Y; Fukunaga K; Fukuda Y; Tozawa K; Kamikozuru K; Ohnishi K; Kusaka T; Kosaka T; Hida N; Ohda Y; Miwa H; Matsumoto T
    Dig Dis Sci; 2007 Oct; 52(10):2725-31. PubMed ID: 17404876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.
    Dignass A; Akbar A; Hart A; Subramanian S; Bommelaer G; Baumgart DC; Grimaud JC; Cadiot G; Makins R; Hoque S; Bouguen G; Bonaz B
    J Crohns Colitis; 2016 Jul; 10(7):812-20. PubMed ID: 26818659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis.
    Yanagisawa K; Murakami M; Kondo Y; Oguma S; Kobayashi S; Miyasaka H; Shinohara T; Tomori A; Nakano Y; Furuhata S; Ikezoe M
    Ther Apher Dial; 2019 Jun; 23(3):217-223. PubMed ID: 31025815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
    Yokoyama Y; Watanabe K; Ito H; Nishishita M; Sawada K; Okuyama Y; Okazaki K; Fujii H; Nakase H; Masuda T; Fukunaga K; Andoh A; Nakamura S
    Cytotherapy; 2015 May; 17(5):680-8. PubMed ID: 25804800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
    Sakimura K; Omori T; Iwashita E; Yoshida T; Tsuzuki Y; Fujimori K; Konishi F; Yoshida Y; Anzai H; Suzuki H; Sugawara S; Takeda Y; Hiraishi K; Saniabadi AR; Ide T; Miura S; Ota S
    Dig Dis Sci; 2006 Sep; 51(9):1525-31. PubMed ID: 16902810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: a prospective cohort study.
    Yamamoto T; Umegae S; Matsumoto K
    Inflamm Bowel Dis; 2010 Nov; 16(11):1905-11. PubMed ID: 20310015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
    Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
    Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?
    Panés J; Guilera M; Ginard D; Hinojosa J; González-Carro P; González-Lara V; Varea V; Domènech E; Badia X
    Dig Liver Dis; 2007 Jul; 39(7):617-25. PubMed ID: 17531555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy.
    Sagawa T; Kakizaki S; Tomizawa T; Nakayama T; Tanaka H; Tojima H; Sato K; Kusano M; Okamura S; Yamada M
    Colorectal Dis; 2016 Jul; 18(7):696-702. PubMed ID: 26748553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.